About Sphingosine 1-phosphate receptor 4
Sphingosine 1-phosphate receptor 4 (S1PR4) is a protein
from Homo sapiens identified by UniProt accession
O95977, 384 residues long.
MolForge cross-references it against 0 known binders and
135 disease associations.
Target properties
| Protein name | Sphingosine 1-phosphate receptor 4 |
| UniProt accession | O95977 |
| Gene | S1PR4 |
| Organism | Homo sapiens |
| Length | 384 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (5)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (135)
Diseases linked to this target (Open Targets).
- leukocyte count · score 0.64
- neutrophil count · score 0.61
- monocyte count · score 0.61
- eosinophil count · score 0.60
- multiple sclerosis · score 0.59
- relapsing-remitting multiple sclerosis · score 0.59
- ulcerative colitis · score 0.54
- basophil percentage of leukocytes · score 0.53
- eosinophil percentage of leukocytes · score 0.52
- lymphocyte count · score 0.44
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O95977-F1 | alphafold | PREDICTED | 78.37 | — |
Amino-acid sequence (384 residues)
MNATGTPVAP ESCQQLAAGG HSRLIVLHYN HSGRLAGRGG PEDGGLGALR GLSVAASCLV VLENLLVLAA ITSHMRSRRW VYYCLVNITL SDLLTGAAYL ANVLLSGART FRLAPAQWFL REGLLFTALA ASTFSLLFTA GERFATMVRP VAESGATKTS RVYGFIGLCW LLAALLGMLP LLGWNCLCAF DRCSSLLPLY SKRYILFCLV IFAGVLATIM GLYGAIFRLV QASGQKAPRP AARRKARRLL KTVLMILLAF LVCWGPLFGL LLADVFGSNL WAQEYLRGMD WILALAVLNS AVNPIIYSFR SREVCRAVLS FLCCGCLRLG MRGPGDCLAR AVEAHSGAST TDSSLRPRDS FRGSRSLSFR MREPLSSISS VRSI
Explore Sphingosine 1-phosphate receptor 4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets